Tumor spectrum analysis in p53-mutant mice.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Current Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0960-9822(00)00002-6PMID 7922305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

  1993cited by this paper
• Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

  1993cited by this paper
• Gain of function mutations in p53

  1993cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• A death in the life of p53

  1993cited by this paper
• p53 and the Li-Fraumeni syndrome.

  1993cited by this paper
• Cancer. A death in the life of p53.

  1993cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• Thymocyte apoptosis induced by p53-dependent and independent pathways

  1993cited by this paper
• Wild-type p53 binds to the TATA-binding protein and represses transcription.

  1992cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression.

  1992cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

  1992cited by this paper
• Effects of an Rb mutation in the mouse

  1992cited by this paper
• Wild-type p53 activates transcription in vitro

  1992cited by this paper
• Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Requirement for a functional Rb-1 gene in murine development

  1992cited by this paper
• Oncogenic forms of p53 inhibit p53-regulated gene expression

  1992cited by this paper
• Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

  1992cited by this paper
• Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Identification of p53 as a sequence-specific DNA-binding protein

  1991cited by this paper
• Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

  1991cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Transgenic mice as probes into complex systems.

  1989cited by this paper
• Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

  1989cited by this paper
• Altering the genome by homologous recombination.

  1989cited by this paper
• Developmental Biology of T Lymphocytes

  1988cited by this paper
• Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes

  1988cited by this paper
• The developmental biology of T lymphocytes.

  1988cited by this paper
• Teratocarcinomas and embryonic stem cells : a practical approach

  1987cited by this paper
• Transgenesis by means of blastocyst-derived embryonic stem cell lines.

  1986cited by this paper
• Precise epitope mapping of the murine transformation‐associated protein, p53.

  1985cited by this paper
• Analysis of the gene coding for the murine cellular tumour antigen p53.

  1984cited by this paper
• Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

  1984cited by this paper

• TET2 and TP53 Mutations Cooperatively Modulate the Response to Inflammation to Promote Leukemic Transformation

  2026cites this paper
• DiLiCre2.0 mouse model: An advanced genome-editing tool to induce mutagenesis in vivo with high spatio-temporal resolution.

  2026cites this paper
• Critical role of cell competition in gliomagenesis

  2026cites this paper
• Fibrillarin: bridging ribosome biogenesis and apoptosis in cellular stress and disease

  2026cites this paper
• Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS.

  2025cites this paper
• Cse1l Regulates Neural Crest Cell Survival and is Critical for Craniofacial and Cardiac Development

  2025cites this paper
• Targeting PIK3CB/YAP1 improves the sensitivity of paclitaxel by suppressing aging in head and neck squamous tumor cells

  2025cites this paper
• Mice carrying nonsense mutant p53 develop frequent multicentric or metastatic tumors

  2025influential citation
• Dissecting cross‐lineage tumourigenesis under p53 inactivation through single‐cell multi‐omics and spatial transcriptomics

  2025cites this paper
• Long noncoding RNA-dependent control of Myc transcriptional bursting

  2025cites this paper
• Mutant p53: evolving perspectives

  2025cites this paper
• Microbiota does not influence tumor development in two models of heritable cancer

  2025cites this paper
• Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment

  2025cites this paper
• Mouse ZGRF1 helicase facilitates DNA repair and maintains efficient fertility

  2025cites this paper
• Age distinguishes selection from causation in cancer genomes

  2025cites this paper
• G-quadruplexes as a source of vulnerability in BRCA2-deficient granule cell progenitors and medulloblastoma

  2025cites this paper
• Germline TP53 p.R337H and XAF1 p.E134* Variants: Prevalence in Paraguay and Comparison with Rates in Brazilian State of Paraná and Previous Findings at the Paraguayan–Brazilian Border

  2025cites this paper
• Harnessing p53 for targeted cancer therapy: new advances and future directions

  2025cites this paper
• Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformation

  2025cites this paper
• Oncogenic and teratogenic effects of Trp53Y217C, an inflammation-prone mouse model of the human hotspot mutant TP53Y220C

  2025cites this paper
• Cse1l is Critical for Cell Survival, Craniofacial and Cardiac Development.

  2025cites this paper
• Preclinical models of soft tissue sarcomas - generation and applications to enhance translational research.

  2025cites this paper
• Inhibition of Ribosome Biogenesis In Vivo Causes p53-Dependent Death and p53-Independent Dysfunction

  2025cites this paper
• Computational prediction of human genetic variants in the mouse genome.

  2025cites this paper
• Lnk deficiency enhances translesion synthesis to alleviate replication stress and promote hematopoietic stem cell fitness

  2025cites this paper
• In vivo cancer modeling using mouse models.

  2025cites this paper
• New insights into coordinated regulation of AHR promoter transcription; molecular mechanisms and therapeutic targets

  2025cites this paper
• Computational modeling of human genetic variants in mice

  2025cites this paper
• Cytokinetic abscission failures in a polarized epithelium affect apical membrane size and cilia

  2025cites this paper
• The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinoma

  2025cites this paper
• Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer.

  2025cites this paper
• Mis-splicing drives loss of function of p53E224D point mutation

  2025cites this paper
• HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab Deruxtecan

  2025cites this paper
• Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy.

  2024cites this paper
• Tbx1 haploinsufficiency leads to local skull deformity, paraflocculus and flocculus dysplasia, and motor-learning deficit in 22q11.2 deletion syndrome

  2024cites this paper
• Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion

  2024cites this paper
• MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model

  2024cites this paper
• The relationship between ethics and innovation: specifically regarding the application and ethical considerations of artificial intelligence in animal models

  2024cites this paper
• Single-cell and bulk transcriptional profiling of mouse ovaries reveals novel genes and pathways associated with DNA damage response in oocytes

  2024cites this paper
• Gene therapy for diffuse pleural mesotheliomas in preclinical models by concurrent expression of NF2 and SuperHippo

  2024cites this paper
• Engineered extrachromosomal oncogene amplifications promote tumorigenesis

  2024cites this paper
• Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma

  2024cites this paper
• Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.

  2024cites this paper
• Eliminating elevated p53 signaling fails to rescue skeletal muscle defects or extend survival in lamin A/C-deficient mice

  2024cites this paper
• Mouse models to investigate in situ cell fate decisions induced by p53

  2024cites this paper
• Toxoplasma gondii infection supports the infiltration of T cells into brain tumors.

  2024cites this paper
• Genetic Screen in a Pre-Clinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities.

  2024cites this paper
• G-quadruplexes are a source of vulnerability in BRCA2 deficient granule cell progenitors and medulloblastoma

  2024cites this paper
• Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis

  2024cites this paper
• Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity

  2024cites this paper
• p53/MDM2 signaling pathway in aging, senescence and tumorigenesis.

  2024cites this paper
• DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy

  2024cites this paper
• The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability

  2024cites this paper
• Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis

  2024cites this paper
• Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice

  2024cites this paper
• Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer

  2024cites this paper
• PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis

  2024cites this paper
• Methods to study xenografted human cancer in genetically diverse mice

  2024cites this paper
• A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer

  2024cites this paper
• Trp53 Deletion Promotes Exacerbated Colitis, Facilitates Lgr5+ Cancer Stem Cell Expansion, and Fuels Tumorigenesis in AOM/DSS-Induced Colorectal Cancer

  2024cites this paper
• The Evolution of Mouse Models of Cancer: Past, Present, and Future.

  2024cites this paper
• Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts

  2024cites this paper
• Ketogenic diet induces p53-dependent cellular senescence in multiple organs

  2024cites this paper
• MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model

  2024cites this paper
• p53 promotes revival stem cells in the regenerating intestine after severe radiation injury

  2024cites this paper
• Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP

  2024cites this paper
• p53 promotes revival stem cells in the regenerating intestine after severe radiation injury

  2023cites this paper
• Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program.

  2023cites this paper
• A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer

  2023cites this paper
• KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition

  2023cites this paper
• NEF-INDUCED HIV-ASSOCIATED NEPHROPATHY THROUGH HCK/LYN.

  2023cites this paper
• Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage

  2023cites this paper
• Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer

  2023cites this paper
• Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program

  2023cites this paper
• Overexpression of Pdx1, reduction of p53, or deletion of CHOP attenuates pancreas hypoplasia in mice with pancreas-specific O-GlcNAc transferase deletion

  2023cites this paper
• C9orf72 poly(PR) mediated neurodegeneration is associated with nucleolar stress

  2023cites this paper
• Cellular dynamics of distinct skeletal cells and the development of osteosarcoma

  2023cites this paper
• PTCH1 mutant human cerebellar organoids are associated with altered neural development and early pathways of medulloblastoma oncogenesis

  2023cites this paper
• Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington's disease.

  2023cites this paper
• Genetic Screen in a Pre-Clinical Model of High-Grade Complex Karyotype Sarcoma Characterizes Drivers of Distinct Sarcoma Subtypes and Identifies New Therapeutic Vulnerabilities

  2023cites this paper
• Extensive elimination of acinar cells during normal postnatal pancreas growth.

  2023cites this paper
• Mutations, Bottlenecks, and Clonal Sweeps: How Environmental Carcinogens and Genomic Changes Shape Clonal Evolution during Tumor Progression.

  2023cites this paper
• Immortalised murine R349P desmin knock-in myotubes exhibit a reduced proton leak and decreased ADP/ATP translocase levels in purified mitochondria

  2023influential citation
• The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells.

  2023cites this paper
• Pharmacological reactivation of p53 in the era of precision anticancer medicine

  2023cites this paper
• Targeting sphingosine kinase 1 in p53KO thymic lymphoma

  2023cites this paper
• A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer

  2023influential citation
• Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells

  2023cites this paper
• Mis-splicing Drives Loss of Function of p53E224D Point Mutation

  2023cites this paper
• How CRISPR Is Revolutionizing the Generation of New Models for Cancer Research.

  2023cites this paper
• XLF/Cernunnos loss impairs mouse brain development by altering symmetric proliferative divisions of neural progenitors.

  2023cites this paper
• Mouse models in colon cancer, inferences, and implications

  2023cites this paper
• P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition

  2023cites this paper
• Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates

  2023cites this paper
• Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation

  2023cites this paper
• Characterization of a rhabdomyosarcoma reveals a critical role for SMG7 in cancer cell viability and tumor growth

  2023cites this paper
• Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice

  2022cites this paper
• Senescence and cancer — role and therapeutic opportunities

  2022cites this paper
• p53 Controls Meiotic Prophase Progression and Crossover Formation

  2022influential citation
• Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner

  2022influential citation